Truist Securities on Nuvation Bio Inc (NUVB): safusidenib opportunity 'represents meaningful upside'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NYSE: NUVB) | Delayed: 4.57 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.57 | 52 Week High | $ | |||
| Open | $4.57 | 52 Week Low | $ | |||
| Day High | $4.57 | P/E | N/A | |||
| Day Low | $4.57 | EPS | $ | |||
| Volume | 591 | |||||
